Tuesday, January 5, 2010

European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

Pfizer Inc. announced today that the European Commission has approved Revatio® (sildenafil) solution for injection for patients who are currently prescribed oral Revatio and who are temporarily unable to take oral medicine, but are otherwise clinically and haemodynamically stable.

The details can be read here.

No comments: